We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Extended duration of the detectable stage by adding HPV test in cervical cancer screening.
- Authors
van den Akker-van Marie, M. E.; van Ballegooijen, M.; Rozendaal, L.; Meijer, C. J. L. M.; Habbema, J. D. F.
- Abstract
The human papillomavirus test (HPV) test could improve the (cost-) effectiveness of cervical screening by selecting women with a very low risk for cervical cancer during a long period. An analysis of a longitudinal study suggests that women with a negative Pap smear and a negative HPV test have a strongly reduced risk of developing cervical abnormalities in the years following the test, and that HPV testing lengthens the detectable stage by 2-5 years, compared to Pap smear detection alone.
- Subjects
CERVICAL cancer; PAPILLOMAVIRUSES; PAP test; CANCER in women; TUMOR diagnosis; PAPILLOMAVIRUS disease diagnosis; RESEARCH; CLINICAL trials; RESEARCH methodology; MEDICAL screening; CERVICAL intraepithelial neoplasia; EVALUATION research; TUMOR classification; COMPARATIVE studies; PAPILLOMAVIRUS diseases; CERVIX uteri tumors; SENSITIVITY &; specificity (Statistics); TUMORS; DISEASE complications
- Publication
British Journal of Cancer, 2003, Vol 89, Issue 10, p1830
- ISSN
0007-0920
- Publication type
journal article
- DOI
10.1038/sj.bjc.6601355